Atlas Trials

Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant Tumor

Clinical trial NCT03662815 · UNKNOWN

Trial details

NCT number
NCT03662815
Sponsor
Sir Run Run Shaw Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Malignant Solid Tumor
Start date
2018-02-07
Primary completion
2021-05-20
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.